Knight Therapeutics Средняя величина рекомендации
Что обозначает Средняя величина рекомендации в Knight Therapeutics?
Средняя величина рекомендации Knight Therapeutics, Inc. является 1.90
Какое определение для Средняя величина рекомендации?
Средняя величина рекомендации является средним значением рейтингов аналитиков от 1,0 (активно покупать) до 5,0 (активно продавать).
Mean of recommendations is an average of ratings from different analysts but it should still be used with other research and investment metrics in order to make investment decisions. It is important to understand a firm's entire scale when assimilating ratings. Additionally, analyst recommendations on stocks owned by firms employing them may be seen as potentially biased.
Financial analysts are often employed by mutual and pension funds, hedge funds, securities firms, banks, investment banks, insurance companies, and other businesses, helping these companies or their clients make investment decisions. Financial analysts employed in commercial lending perform "balance sheet analysis," examining the audited financial statements and corollary data in order to assess lending risks. In a stock brokerage house or in an investment bank, they read company financial statements and analyze commodity prices, sales, costs, expenses, and tax rates in order to determine a company's value and project future earnings. In any of these various institutions, the analyst often meets with company officials to gain a better insight into a company's prospects and to determine the company's managerial effectiveness.
Usually, financial analysts study an entire industry, assessing current trends in business practices, products, and industry competition. They must keep abreast of new regulations or policies that may affect the industry, as well as monitor the economy to determine its effect on earnings.
Средняя величина рекомендации компаний в Health Care сектор на TSX по сравнению с Knight Therapeutics
Что делает Knight Therapeutics?
Knight Therapeutics Inc., a specialty pharmaceutical company, develops, acquires, in-licenses, out-licenses, markets, and distributes pharmaceutical and consumer health products, and medical devices in Canada and internationally. It offers Bijuva for the treatment of moderate to severe vasomotor symptoms associated with menopause in women with intact uterus; IMVEXXY to treat postmenopausal moderate to severe dyspareunia; IBSRELA for the treatment of irritable bowel syndrome with constipation in adults; TRELSTAR to treat advanced prostate cancer and for pain associated with endometriosis; ILUVIEN for the treatment of vision loss due to diabetic macular oedema; and NERLYNX to treat early-stage breast cancer. The company also provides Burinex, for the treatment of edema associated with congestive heart failure, cirrhosis of the liver, and renal disease, including the nephrotic syndrome; PROBUPHINE, to treat opioid addiction; and MOVANTIK for the treatment of opioid-induced constipation. In addition, it offers Vidaza to treat myelodysplastic syndrome; Abraxane for metastatic pancreatic adenocarcinoma; Halaven to treat advanced or metastatic breast cancer; Lenvima for differentiated thyroid cancer, advanced renal cell cancer, and unresectable hepatocellular carcinoma; Ladevina to treat multiple myeloma; Zyvalix for metastatic prostate cancer; Karfib to treat relapsed or refractory multiple myeloma; Leprid for advanced prostate cancer; AmBisome and Cresemba to treat fungal infection; and Impavido for leishmaniasis. Further, the company provides Ursofalk to treat biliary cirrhosis; Salofalk for ulcerative colitis; Fibridoner to treat idiopathic pulmonary fibrosis; Toliscrin for severe acute or resistant chronic infections; and Tobradosa Haler for chronic lung infections. Additionally, it finances other life science companies; and invests in life sciences venture capital funds. The company was incorporated in 2013 and is headquartered in Montreal, Canada.
Компании с средняя величина рекомендации похож на Knight Therapeutics
- Univar Solutions Inc имеет Средняя величина рекомендации из 1.89
- Umpqua Corp имеет Средняя величина рекомендации из 1.89
- Tivity Health Inc имеет Средняя величина рекомендации из 1.89
- Immunogen имеет Средняя величина рекомендации из 1.89
- Accenture plc имеет Средняя величина рекомендации из 1.89
- Merit Medical Systems имеет Средняя величина рекомендации из 1.89
- Knight Therapeutics имеет Средняя величина рекомендации из 1.90
- Sunrun Inc имеет Средняя величина рекомендации из 1.91
- Ryanair Plc имеет Средняя величина рекомендации из 1.91
- Esperion Therapeutics имеет Средняя величина рекомендации из 1.91
- Macrogenics Inc имеет Средняя величина рекомендации из 1.91
- Ecopetrol SA имеет Средняя величина рекомендации из 1.91
- Procter & Gamble Co имеет Средняя величина рекомендации из 1.91